嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06998 嘉和生物-B

交易中 07-16 15:06:01

2.430

+0.070

+2.97%

最高2.450	最低2.390	成交量41.95万
今开2.390	昨收2.360	日振幅2.54%
总市值12.76亿	流通市值12.76亿	总股本5.25亿
成交额101.55万	换手率0.08%	流通股本5.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"嘉和生物-B","latestPrice":2.43,"timestamp":1752647006230,"preClose":2.36,"halted":0,"volume":419500,"delay":0,"floatShares":525000000,"shares":525000000,"eps":-0.10915296653609753,"marketStatus":"交易中","change":0.07,"latestTime":"07-16 15:06:01","open":2.39,"high":2.45,"low":2.39,"amount":1015475,"amplitude":0.025424,"askPrice":2.45,"askSize":1000,"bidPrice":2.43,"bidSize":78000,"shortable":0,"etf":0,"ttmEps":-0.10930599492899813,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752653400000},"marketStatusCode":2,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":2.36,"openAndCloseTimeList":[[1752629400000,1752638400000],[1752642000000,1752652800000]],"volumeRatio":0.962754,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2550967099","title":"沃森生物：持有圣诺医药和嘉和生物部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2550967099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550967099?lang=zh_cn&edition=full","pubTime":"2025-07-11 08:49","pubTimestamp":1752194948,"startTime":"0","endTime":"0","summary":"证券之星消息，沃森生物(300142)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问贵司截止目前直接或间接持有嘉禾生物、圣诺医药分别多少股权。沃森生物回复：尊敬的投资者，您好！公司持有圣诺医药和嘉和生物部分股权，持股比例分别约为3.42%和7.15%。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100005790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","06998","300142","BK0070","BK1583","02257","BK1161","BK0077","BK1574","BK0239"],"gpt_icon":0},{"id":"2550161750","title":"嘉和生物-B07月10日主力净流出20.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2550161750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550161750?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:15","pubTimestamp":1752135338,"startTime":"0","endTime":"0","summary":"07月10日, 嘉和生物-B股价跌2.83%，报收2.40元，成交金额122.6万元，换手率0.10%，振幅2.83%，量比1.44。嘉和生物-B今日主力资金净流出20.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.83%，主力资金累计净流出20.4万元；近20日主力资金累计净流出55.3万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165543a6a1387c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710165543a6a1387c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2548701837","title":"嘉和生物-B盘中异动 早盘快速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548701837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548701837?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:00","pubTimestamp":1751421650,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘10时00分，嘉和生物-B股票出现异动，股价大幅拉升5.37%。截至发稿，该股报2.550港元/股，成交量7.1万股，换手率0.01%，振幅4.13%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，华昊中天医药-B、加科思-B、君实生物涨幅较大，振幅较大的相关个股有华昊中天医药-B、科笛-B、药捷安康-B，振幅分别为74.15%、18.36%、9.95%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210005195334db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210005195334db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0},{"id":"2547090058","title":"嘉和生物-B：被许可人于其许可引入的新型T细胞衔接器用于自身免疫性疾病临床评估方面取得进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090058","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090058?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:18","pubTimestamp":1751293080,"startTime":"0","endTime":"0","summary":"格隆汇6月30日丨嘉和生物-B宣布，公司获GB261的被许可人Candid Therapeutics, Inc.告知，被许可人于其许可引入的新型T细胞衔接器用于自身免疫性疾病临床评估方面取得进展。首批患者已接受TCE给药且耐受性良好。GB261具备低CD3亲和力，经优化后可降低T细胞过度活化的风险，同时维持强效且具选择性的B细胞清除能力。被许可人是一家处于临床阶段的生物科技公司，专注于通过新型T细胞衔接器平台改变自身免疫性及炎症性疾病的治疗方法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630222000a72659b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630222000a72659b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0},{"id":"2546207307","title":"嘉和生物-B：崔白已获委任为提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2546207307","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546207307?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:41","pubTimestamp":1750927302,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，根据组织章程细则第16.19条，吕东博士于股东周年大会上轮席告退非执行董事职位，且由于工作变动，无意于股东周年大会上膺选连任。因此，彼作为提名委员会成员的职位亦已空出，自股东周年大会结束起生效。崔白女士已获委任为提名委员会成员，自2025年6月26日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626164406978fab04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626164406978fab04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","06998","BK1161"],"gpt_icon":0},{"id":"2545924604","title":"嘉和生物-B06月23日主力净流入19.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545924604","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545924604?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:15","pubTimestamp":1750666520,"startTime":"0","endTime":"0","summary":"06月23日, 嘉和生物-B股价涨1.20%，报收2.53元，成交金额245.1万元，换手率0.19%，振幅6.80%，量比0.77。嘉和生物-B今日主力资金净流入19.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌9.32%，主力资金累计净流出6.9万元；近20日主力资金累计净流入191.6万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623171541a4b89a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623171541a4b89a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","06998","BK1574"],"gpt_icon":0},{"id":"2543623147","title":"嘉和生物-B盘中异动 快速跳水5.80%报2.760港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543623147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543623147?lang=zh_cn&edition=full","pubTime":"2025-06-16 15:15","pubTimestamp":1750058145,"startTime":"0","endTime":"0","summary":"2025年06月16日下午盘15时15分，嘉和生物-B股票出现波动，股价大幅下跌5.80%。截至发稿，该股报2.760港元/股，成交量164.45万股，换手率0.31%，振幅8.87%。资金方面，该股资金流入135.823万港元，流出320.084万港元。嘉和生物-B股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，北海康成-B、帝王国际投资、歌礼制药-B涨幅较大，振幅较大的相关个股有北海康成-B、帝王国际投资、歌礼制药-B，振幅分别为55.38%、19.00%、18.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616151545951e5668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616151545951e5668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06998","BK1583"],"gpt_icon":0},{"id":"2543573940","title":"嘉和生物-B盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543573940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543573940?lang=zh_cn&edition=full","pubTime":"2025-06-13 10:58","pubTimestamp":1749783519,"startTime":"0","endTime":"0","summary":"2025年06月13日早盘10时58分，嘉和生物-B股票出现波动，股价大幅下挫5.03%。截至发稿，该股报2.830港元/股，成交量207.1万股，换手率0.39%，振幅5.03%。嘉和生物-B股票所在的生物技术行业中，整体跌幅为1.81%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613105839a70684e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613105839a70684e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"2542300715","title":"嘉和生物-B06月11日主力净流出44.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2542300715","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542300715?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:15","pubTimestamp":1749629749,"startTime":"0","endTime":"0","summary":"06月11日, 嘉和生物-B股价跌1.83%，报收2.68元，成交金额194.3万元，换手率0.14%，振幅2.93%，量比0.62。嘉和生物-B今日主力资金净流出44.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.83%，主力资金累计净流出44.0万元；近20日主力资金累计净流入181.1万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611174251a7037ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611174251a7037ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0},{"id":"2542695875","title":"嘉和生物-B盘中异动 股价大涨5.91%报2.690港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542695875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542695875?lang=zh_cn&edition=full","pubTime":"2025-06-09 10:10","pubTimestamp":1749435038,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘10时10分，嘉和生物-B股票出现异动，股价急速上涨5.91%。截至发稿，该股报2.690港元/股，成交量18.4万股，换手率0.04%，振幅6.30%。资金方面，该股资金流入46.841万港元，流出1.1535万港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为2.83%。其相关个股中，帝王国际投资、金斯瑞生物科技、中国抗体-B涨幅较大，振幅较大的相关个股有帝王国际投资、中国抗体-B、欧康维视生物-B，振幅分别为32.91%、16.90%、13.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609101039a49f9214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609101039a49f9214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2540914034","title":"嘉和生物-B盘中异动 下午盘股价大涨5.02%报2.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540914034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540914034?lang=zh_cn&edition=full","pubTime":"2025-06-04 15:20","pubTimestamp":1749021650,"startTime":"0","endTime":"0","summary":"2025年06月04日下午盘15时20分，嘉和生物-B股票出现异动，股价快速拉升5.02%。截至发稿，该股报2.720港元/股，成交量173.65万股，换手率0.33%，振幅5.79%。资金方面，该股资金流入304.932万港元，流出134.84万港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为2.47%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604152050a4997444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604152050a4997444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2540149710","title":"嘉和生物-B盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540149710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540149710?lang=zh_cn&edition=full","pubTime":"2025-06-03 09:51","pubTimestamp":1748915467,"startTime":"0","endTime":"0","summary":"2025年06月03日早盘09时51分，嘉和生物-B股票出现波动，股价快速上涨5.51%。截至发稿，该股报2.680港元/股，成交量12.5万股，换手率0.02%，振幅7.09%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为1.61%。其相关个股中，乐普生物-B、康诺亚-B、泰格医药涨幅较大，振幅较大的相关个股有宜明昂科-B、康宁杰瑞制药-B、昭衍新药，振幅分别为11.94%、9.95%、9.52%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603095107a6f7d458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603095107a6f7d458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","06998"],"gpt_icon":0},{"id":"2540564897","title":"嘉和生物-B盘中异动 早盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540564897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540564897?lang=zh_cn&edition=full","pubTime":"2025-06-02 09:32","pubTimestamp":1748827922,"startTime":"0","endTime":"0","summary":"2025年06月02日早盘09时32分，嘉和生物-B股票出现异动，股价大幅下挫5.20%。截至发稿，该股报2.550港元/股，成交量11.15万股，换手率0.02%，振幅5.58%。嘉和生物-B股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，同源康医药-B、中国抗体-B、永泰生物-B涨幅较大，振幅较大的相关个股有复宏汉霖、宜明昂科-B、MIRXES-B，振幅分别为7.82%、7.76%、6.68%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602093202950b0267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602093202950b0267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"1104419892","title":"异动解读 | 嘉和生物-B获新药批准，股价盘中大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104419892","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104419892?lang=zh_cn&edition=full","pubTime":"2025-05-30 09:46","pubTimestamp":1748569589,"startTime":"0","endTime":"0","summary":"港股嘉和生物-B今日盘中大涨5.30%，引发市场关注。该涨幅与公司重要新药获批有关。据悉，中国国家药品监督管理局已批准嘉和生物的来罗西利新药上市申请。这一批准标志着嘉和生物在肿瘤治疗领域取得重大突破。新药的获批不仅有望为相关患者带来新的治疗选择，也可能为公司带来新的收入来源，推动公司业务发展。投资者对此反应积极，推动股价大幅上涨。后市表现仍需持续关注公司新药的商业化进展及市场反响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 嘉和生物-B获新药批准，股价盘中大涨5.30%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2539556352","title":"嘉和生物-B(06998)因购股权获行使而发行48.82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2539556352","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539556352?lang=zh_cn&edition=full","pubTime":"2025-05-29 17:37","pubTimestamp":1748511422,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，于2025年5月29日，该公司因政总裁根据2023年购股权计划行使购股权而发行48.82万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1574","06998"],"gpt_icon":0},{"id":"2539993237","title":"嘉和生物-B(06998)：中国国家药品监督管理局批准来罗西利(GB491)新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2539993237","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539993237?lang=zh_cn&edition=full","pubTime":"2025-05-29 16:49","pubTimestamp":1748508597,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B 发布公告，中国国家药品监督管理局已批准来罗西利的新药上市申请。NMPA批准来罗西利的新药上市申请将为HR+╱HER2-局部晚期或转移性乳腺癌患者提供更好的治疗选择。董事会向为来罗西利的成功临床开发作出贡献的所有患者及研究人员表示感谢。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"嘉和生物-B(06998)：中国国家药品监督管理局批准来罗西利(GB491)新药上市申请","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","06998"],"gpt_icon":0},{"id":"2538223436","title":"嘉和生物-B盘中异动 下午盘快速拉升5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538223436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538223436?lang=zh_cn&edition=full","pubTime":"2025-05-27 13:18","pubTimestamp":1748323112,"startTime":"0","endTime":"0","summary":"2025年05月27日下午盘13时18分，嘉和生物-B股票出现波动，股价急速上涨5.60%。截至发稿，该股报2.830港元/股，成交量76.6万股，换手率0.15%，振幅7.46%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，维亚生物、乐普生物-B、华领医药-B涨幅较大，振幅较大的相关个股有君实生物、派格生物医药-B、维亚生物，振幅分别为20.43%、14.62%、12.73%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527131832aa2c9986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527131832aa2c9986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2537603881","title":"亿腾医药借壳嘉和生物上市，销售费用高企与分红争议引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2537603881","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537603881?lang=zh_cn&edition=full","pubTime":"2025-05-21 14:18","pubTimestamp":1747808282,"startTime":"0","endTime":"0","summary":"2024年10月，亿腾医药通过反向收购嘉和生物实现港股上市。其长达四年的IPO挫折后选择“借壳”突围，估值达6.77亿美元。然而，公司2024年销售及分销开支飙升至7.31亿元，会议开支达2.23亿元，远超同期研发费用1.22亿元，引发对“重销售轻研发”模式的质疑。此外，上市前半年内突击分红1.44亿元，实控人独得6300万元，被指“掏空式分红”。未来，亿腾嘉和寄希望于创新药管线纳入医保以推动增长，但高销售费用与医保谈判降价压力或成挑战。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521141920976067a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521141920976067a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","06998","BK1583"],"gpt_icon":0},{"id":"2537392675","title":"嘉和生物-B盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537392675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537392675?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:59","pubTimestamp":1747792778,"startTime":"0","endTime":"0","summary":"2025年05月21日早盘09时59分，嘉和生物-B股票出现波动，股价大幅上涨5.04%。截至发稿，该股报2.710港元/股，成交量17.25万股，换手率0.03%，振幅6.20%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为1.59%。其相关个股中，来凯医药-B、亚盛医药-B、康希诺生物涨幅较大，振幅较大的相关个股有来凯医药-B、康希诺生物、亚盛医药-B，振幅分别为17.84%、17.13%、11.86%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505210959389760265b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505210959389760265b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","06998"],"gpt_icon":0},{"id":"2536834668","title":"嘉和生物-B盘中异动 快速上涨5.65%报2.620港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536834668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536834668?lang=zh_cn&edition=full","pubTime":"2025-05-20 10:13","pubTimestamp":1747707211,"startTime":"0","endTime":"0","summary":"2025年05月20日早盘10时13分，嘉和生物-B股票出现异动，股价快速拉升5.65%。截至发稿，该股报2.620港元/股，成交量49.7万股，换手率0.10%，振幅4.84%。资金方面，该股资金流入103.204万港元，流出17.251万港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为2.08%。其相关个股中，基石药业-B、欧康维视生物-B、和铂医药-B涨幅较大，振幅较大的相关个股有基石药业-B、欧康维视生物-B、宜明昂科-B，振幅分别为14.63%、11.40%、11.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520101331a484c093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520101331a484c093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0328},{"period":"1month","weight":-0.1945},{"period":"3month","weight":0.1238},{"period":"6month","weight":0.3111},{"period":"1year","weight":0.8437},{"period":"ytd","weight":0.3642}],"compareEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.1678},{"period":"6month","weight":0.2596},{"period":"1year","weight":0.3649},{"period":"ytd","weight":0.2258}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"嘉和生物药业曼（开曼）控股有限公司是一家主要从事生物制药业务的公司。该公司的主营业务是从事人用生物制药产品的发现、研发及商业化。该公司产品管线包括来罗西利（GB491，Lerociclib）、GB261、GB263T等产品，涵盖乳腺癌、肺癌、胃肠道肿瘤以及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.050516},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004657},{"month":3,"riseRate":0.6,"avgChangeRate":0.024884},{"month":4,"riseRate":0.4,"avgChangeRate":-0.110106},{"month":5,"riseRate":0.6,"avgChangeRate":0.031188},{"month":6,"riseRate":0.6,"avgChangeRate":0.043248},{"month":7,"riseRate":0.2,"avgChangeRate":-0.120746},{"month":8,"riseRate":0.25,"avgChangeRate":-0.022403},{"month":9,"riseRate":0.5,"avgChangeRate":-0.083889},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.044191},{"month":12,"riseRate":0.8,"avgChangeRate":0.080331}],"exchange":"SEHK","name":"嘉和生物-B","nameEN":"GENOR-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉和生物-B,06998,嘉和生物-B股票,嘉和生物-B股票老虎,嘉和生物-B股票老虎国际,嘉和生物-B行情,嘉和生物-B股票行情,嘉和生物-B股价,嘉和生物-B股市,嘉和生物-B股票价格,嘉和生物-B股票交易,嘉和生物-B股票购买,嘉和生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}